Comparative Pharmacology
Head-to-head clinical analysis: AMMONIUM CHLORIDE 0 9 IN NORMAL SALINE versus SILPHEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMMONIUM CHLORIDE 0 9 IN NORMAL SALINE versus SILPHEN.
AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE vs SILPHEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ammonium chloride provides chloride ions to correct hypochloremic metabolic alkalosis and acts as a systemic acidifying agent. It is metabolized to urea and hydrochloric acid in the liver, thereby increasing hydrogen ion concentration in plasma and lowering pH.
N-acetyl-para-aminophenol (APAP) is a centrally and peripherally acting analgesic and antipyretic. Its mechanism involves inhibition of cyclooxygenase (COX) in the central nervous system, reducing prostaglandin synthesis, and activation of descending serotonergic pathways. It does not significantly inhibit peripheral COX or platelet function.
Adults: 0.9% ammonium chloride in normal saline, intravenous infusion at a rate of 0.5-1 mL/kg/hour, typically 500-1000 mL over 4-8 hours, adjusted based on serum chloride and pH. Maximum infusion rate: 1 mL/kg/hour.
1-2 tablets (25-50 mg diphenhydramine HCl) orally every 4-6 hours as needed; maximum 300 mg/day.
None Documented
None Documented
Variable; approximately 2-4 hours depending on renal function and acid-base status; prolonged in renal impairment.
Terminal elimination half-life is 4-6 hours in patients with normal renal function; prolongs to 12-24 hours with creatinine clearance <30 mL/min.
Renal: >95% as ammonium and chloride ions; minimal biliary/fecal elimination.
Renal excretion accounts for 65% of the dose as unchanged drug; hepatic metabolism produces inactive glucuronide conjugates (20%), with biliary/fecal elimination comprising the remaining 15%.
Category C
Category C
Expectorant/Systemic Acidifier
Expectorant